Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8931704rdf:typepubmed:Citationlld:pubmed
pubmed-article:8931704lifeskim:mentionsumls-concept:C0022271lld:lifeskim
pubmed-article:8931704lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:8931704lifeskim:mentionsumls-concept:C0299212lld:lifeskim
pubmed-article:8931704lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:8931704lifeskim:mentionsumls-concept:C0276496lld:lifeskim
pubmed-article:8931704lifeskim:mentionsumls-concept:C1418985lld:lifeskim
pubmed-article:8931704lifeskim:mentionsumls-concept:C0599734lld:lifeskim
pubmed-article:8931704lifeskim:mentionsumls-concept:C0442726lld:lifeskim
pubmed-article:8931704lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:8931704lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:8931704pubmed:issue6lld:pubmed
pubmed-article:8931704pubmed:dateCreated1997-1-6lld:pubmed
pubmed-article:8931704pubmed:abstractTextGermline mutations in the presenilin 1 (PS1) gene apparently account for the majority of early-onset, familial Alzheimer's disease (AD). Using a mutation-screening strategy (denaturing gradient gel electrophoresis; DGGE), we analyzed a large family with early onset AD and seizures. The patients in this family showed a novel missense mutation in exon 5 of the PS1 gene (A to T change in codon 120, altering glutamine to aspartic acid). This novel mutation is located within the second hydrophilic domain of the molecule, a region not particularly involved in previously described germline mutations, and is of unknown biological significance. These results also demonstrate that DGGE can be used effectively to screen for mutations within this gene.lld:pubmed
pubmed-article:8931704pubmed:languageenglld:pubmed
pubmed-article:8931704pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8931704pubmed:citationSubsetIMlld:pubmed
pubmed-article:8931704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8931704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8931704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8931704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8931704pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8931704pubmed:statusMEDLINElld:pubmed
pubmed-article:8931704pubmed:monthDeclld:pubmed
pubmed-article:8931704pubmed:issn0340-6717lld:pubmed
pubmed-article:8931704pubmed:authorpubmed-author:DavidsonMMlld:pubmed
pubmed-article:8931704pubmed:authorpubmed-author:FriedmanEElld:pubmed
pubmed-article:8931704pubmed:authorpubmed-author:KorczynA DADlld:pubmed
pubmed-article:8931704pubmed:authorpubmed-author:GoldmanBBlld:pubmed
pubmed-article:8931704pubmed:authorpubmed-author:ChapmanJJlld:pubmed
pubmed-article:8931704pubmed:authorpubmed-author:TrevesT ATAlld:pubmed
pubmed-article:8931704pubmed:authorpubmed-author:Aharon-Peretz...lld:pubmed
pubmed-article:8931704pubmed:authorpubmed-author:Reznik-WolfHHlld:pubmed
pubmed-article:8931704pubmed:authorpubmed-author:St George...lld:pubmed
pubmed-article:8931704pubmed:issnTypePrintlld:pubmed
pubmed-article:8931704pubmed:volume98lld:pubmed
pubmed-article:8931704pubmed:ownerNLMlld:pubmed
pubmed-article:8931704pubmed:authorsCompleteYlld:pubmed
pubmed-article:8931704pubmed:pagination700-2lld:pubmed
pubmed-article:8931704pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8931704pubmed:meshHeadingpubmed-meshheading:8931704-...lld:pubmed
pubmed-article:8931704pubmed:meshHeadingpubmed-meshheading:8931704-...lld:pubmed
pubmed-article:8931704pubmed:meshHeadingpubmed-meshheading:8931704-...lld:pubmed
pubmed-article:8931704pubmed:meshHeadingpubmed-meshheading:8931704-...lld:pubmed
pubmed-article:8931704pubmed:meshHeadingpubmed-meshheading:8931704-...lld:pubmed
pubmed-article:8931704pubmed:meshHeadingpubmed-meshheading:8931704-...lld:pubmed
pubmed-article:8931704pubmed:meshHeadingpubmed-meshheading:8931704-...lld:pubmed
pubmed-article:8931704pubmed:meshHeadingpubmed-meshheading:8931704-...lld:pubmed
pubmed-article:8931704pubmed:meshHeadingpubmed-meshheading:8931704-...lld:pubmed
pubmed-article:8931704pubmed:meshHeadingpubmed-meshheading:8931704-...lld:pubmed
pubmed-article:8931704pubmed:meshHeadingpubmed-meshheading:8931704-...lld:pubmed
pubmed-article:8931704pubmed:meshHeadingpubmed-meshheading:8931704-...lld:pubmed
pubmed-article:8931704pubmed:meshHeadingpubmed-meshheading:8931704-...lld:pubmed
pubmed-article:8931704pubmed:year1996lld:pubmed
pubmed-article:8931704pubmed:articleTitleA novel mutation of presenilin 1 in familial Alzheimer's disease in Israel detected by denaturing gradient gel electrophoresis.lld:pubmed
pubmed-article:8931704pubmed:affiliationOncogenetics Unit, Chaim Sheba Medical Center, Tel-Hashomer, Israel. feitan@post.tau.ac.illld:pubmed
pubmed-article:8931704pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8931704pubmed:publicationTypeCase Reportslld:pubmed
entrez-gene:5663entrezgene:pubmedpubmed-article:8931704lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8931704lld:pubmed